Forecast & RatingOnly 1 analyst currently covers BioAtla (BCAB.US), with a price target of $500.00 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Apr 6, 2026; this does not constitute investment advice.
Nov 28, 2025Price forecast
$500.0026215.79%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 14, 2026
Forecast met0.0%
Stock price$1.90
Avg. target$500.0
High target$500
Low target$500
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.